CHAPTER 1:INTRODUCTION

1.1.Report description 
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings

2.1.1.Top impacting factors
2.1.2.Top investment pockets

2.2.CXO perspective
2.3.View of Engaged Stakeholders

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Porter's five forces analysis

3.2.1.Bargaining power of suppliers
3.2.2.Bargaining power of buyers
3.2.3.Threat of substitution
3.2.4.Threat of new entrants
3.2.5.Intensity of competitive rivalry

3.3.Parent market overview
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Use of lycopene as a natural coloring agent in food and beverages to drive the market growth
3.4.1.2.Various health benefits of lycopene to benefit the nutraceutical industry
3.4.1.3.Skin repairing and skin improving qualities of lycopene to increase its adoption in cosmetic industry

3.4.2.Restraints

3.4.2.1.Availability of several other sources for red food coloring to impede market growth
3.4.2.2.Low stability of lycopene to challenge market expansion

3.4.3.Opportunities

3.4.3.1.Increase in consumer demand for clean label products can help provide impetus to the market
3.4.3.2.Newer demand from the animal feed industry can help create new growth avenues

3.5.Industry life cycle assessment, by region
3.6.Geographical concentration analysis of lycopene producers

CHAPTER 4:GLOBAL LYCOPENE MARKET, BY FORM

4.1.Overview

4.1.1.Market size and forecast, by Form

4.2.Powder

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Others

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

CHAPTER 5:GLOBAL LYCOPENE MARKET, BY NATURE

5.1.Overview

5.1.1.Market size and forecast, by Nature

5.2.Natural

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Synthetic

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

CHAPTER 6:GLOBAL LYCOPENE MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast, by Application

6.2.Food and Beverage

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country

6.3.Nutraceuticals and Pharmaceuticals

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country

6.4.Cosmetics and Personal Care

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country

CHAPTER 7:LYCOPENE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast, by region

7.2.North America

7.2.1.Overview
7.2.2.Key market trends, growth factors, and opportunities
7.2.3.Market size and forecast, by Form
7.2.4.Market size and forecast, by Nature
7.2.5.Market size and forecast, by Application
7.2.6.Market analysis, by Country

7.2.6.1.U.S.

7.2.6.1.1.Market size and forecast, by Form
7.2.6.1.2.Market size and forecast, by Nature
7.2.6.1.3.Market size and forecast, by Application

7.2.6.2.Canada

7.2.6.2.1.Market size and forecast, by Form
7.2.6.2.2.Market size and forecast, by Nature
7.2.6.2.3.Market size and forecast, by Application

7.2.6.3.Mexico

7.2.6.3.1.Market size and forecast, by Form
7.2.6.3.2.Market size and forecast, by Nature
7.2.6.3.3.Market size and forecast, by Application

7.3.Europe

7.3.1.Overview
7.3.2.Key market trends, growth factors, and opportunities
7.3.3.Market size and forecast, by Form
7.3.4.Market size and forecast, by Nature
7.3.5.Market size and forecast, by Application
7.3.6.Market analysis, by Country

7.3.6.1.UK

7.3.6.1.1.Market size and forecast, by Form
7.3.6.1.2.Market size and forecast, by Nature
7.3.6.1.3.Market size and forecast, by Application

7.3.6.2.Germany

7.3.6.2.1.Market size and forecast, by Form
7.3.6.2.2.Market size and forecast, by Nature
7.3.6.2.3.Market size and forecast, by Application

7.3.6.3.France

7.3.6.3.1.Market size and forecast, by Form
7.3.6.3.2.Market size and forecast, by Nature
7.3.6.3.3.Market size and forecast, by Application

7.3.6.4.Italy

7.3.6.4.1.Market size and forecast, by Form
7.3.6.4.2.Market size and forecast, by Nature
7.3.6.4.3.Market size and forecast, by Application

7.3.6.5.Spain

7.3.6.5.1.Market size and forecast, by Form
7.3.6.5.2.Market size and forecast, by Nature
7.3.6.5.3.Market size and forecast, by Application

7.3.6.6.Rest of Europe

7.3.6.6.1.Market size and forecast, by Form
7.3.6.6.2.Market size and forecast, by Nature
7.3.6.6.3.Market size and forecast, by Application

7.4.Asia-Pacific

7.4.1.Overview
7.4.2.Key market trends, growth factors, and opportunities
7.4.3.Market size and forecast, by Form
7.4.4.Market size and forecast, by Nature
7.4.5.Market size and forecast, by Application
7.4.6.Market analysis, by country

7.4.6.1.China

7.4.6.1.1.Market size and forecast, by Form
7.4.6.1.2.Market size and forecast, by Nature
7.4.6.1.3.Market size and forecast, by Application

7.4.6.2.Japan

7.4.6.2.1.Market size and forecast, by Form
7.4.6.2.2.Market size and forecast, by Nature
7.4.6.2.3.Market size and forecast, by Application

7.4.6.3.India

7.4.6.3.1.Market size and forecast, by Form
7.4.6.3.2.Market size and forecast, by Nature
7.4.6.3.3.Market size and forecast, by Application

7.4.6.4.ASEAN

7.4.6.4.1.Market size and forecast, by Form
7.4.6.4.2.Market size and forecast, by Nature
7.4.6.4.3.Market size and forecast, by Application

7.4.6.5.Australia

7.4.6.5.1.Market size and forecast, by Form
7.4.6.5.2.Market size and forecast, by Nature
7.4.6.5.3.Market size and forecast, by Application

7.4.6.6.South Korea

7.4.6.6.1.Market size and forecast, by Form
7.4.6.6.2.Market size and forecast, by Nature
7.4.6.6.3.Market size and forecast, by Application

7.4.6.7.Rest of Asia-Pacific

7.4.6.7.1.Market size and forecast, by Form
7.4.6.7.2.Market size and forecast, by Nature
7.4.6.7.3.Market size and forecast, by Application

7.5.LAMEA

7.5.1.Overview
7.5.2.Key market trends, growth factors, and opportunities
7.5.3.Market size and forecast, by Form
7.5.4.Market size and forecast, by Nature
7.5.5.Market size and forecast, by Application
7.5.6.Market analysis, by country

7.5.6.1.Brazil

7.5.6.1.1.Market size and forecast, by Form
7.5.6.1.2.Market size and forecast, by Nature
7.5.6.1.3.Market size and forecast, by Application

7.5.6.2.Argentina

7.5.6.2.1.Market size and forecast, by Form
7.5.6.2.2.Market size and forecast, by Nature
7.5.6.2.3.Market size and forecast, by Application

7.5.6.3.Saudi Arabia

7.5.6.3.1.Market size and forecast, by Form
7.5.6.3.2.Market size and forecast, by Nature
7.5.6.3.3.Market size and forecast, by Application

7.5.6.4.South Africa

7.5.6.4.1.Market size and forecast, by Form
7.5.6.4.2.Market size and forecast, by Nature
7.5.6.4.3.Market size and forecast, by Application

7.5.6.5.Rest of LAMEA

7.5.6.5.1.Market size and forecast, by Form
7.5.6.5.2.Market size and forecast, by Nature
7.5.6.5.3.Market size and forecast, by Application

CHAPTER 8:COMPETITION LANDSCAPE

8.1.Overview
8.2.Competitive dashboard
8.3.Competitive heat map
8.4.Product mapping
8.5.Top winning strategies
8.6.Key developments

8.6.1.Acquisition
8.6.2.Business Expansion
8.6.3.Product Launch
8.6.4.Partnership
8.6.5.Agreement
8.6.6.Collaboration
8.6.7.Joint venture
8.6.8.Merger

8.7.Top Player Positioning

CHAPTER 9:COMPANY PROFILE

9.1.ALLIED BIOTECH CORPORATION

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio

9.2.ARCHER DANIELS MIDLAND COMPANY

9.2.1.Company overview
9.2.2.Key executive
9.2.3.Company snapshot
9.2.4.Operating business segments
9.2.5.Product portfolio
9.2.6.R&D expenditure
9.2.7.Business performance
9.2.8.Key strategic moves and developments

9.3.AROMATAGROUP SRL

9.3.1.Company overview
9.3.2.Key Executives
9.3.3.Company snapshot
9.3.4.Operating business segments
9.3.5.Product portfolio
9.3.6.Key strategic moves and developments

9.4.BASF SE

9.4.1.Company overview
9.4.2.Key Executives
9.4.3.Company snapshot
9.4.4.Operating business segments
9.4.5.Product portfolio
9.4.6.Business performance
9.4.7.Key strategic moves and developments

9.5.DIVIS LABORATORIES LTD.

9.5.1.Company overview
9.5.2.Key Executives
9.5.3.Company snapshot
9.5.4.Operating business segments
9.5.5.Product portfolio
9.5.6.Business performance
9.5.7.Key strategic moves and developments

9.6.DOEHLER GROUP SE

9.6.1.Company overview
9.6.2.Key Executives
9.6.3.Company snapshot
9.6.4.Operating business segments
9.6.5.Product portfolio

9.7.EXCELVITE

9.7.1.Company overview
9.7.2.Key Executives
9.7.3.Company snapshot
9.7.4.Operating business segments
9.7.5.Product portfolio

9.8.Givaudan International SA (NATUREX S.A.)

9.8.1.Company overview
9.8.2.Key executive
9.8.3.Company snapshot
9.8.4.Operating business segments
9.8.5.Product portfolio
9.8.6.R&D expenditure
9.8.7.Business performance
9.8.8.Key strategic moves and developments

9.9.KALSEC INC.

9.9.1.Company overview
9.9.2.Key Executives
9.9.3.Company snapshot
9.9.4.Operating business segments
9.9.5.Product portfolio

9.10.KONINKLIJKE DSM N.V.

9.10.1.Company overview
9.10.2.Key executive
9.10.3.Company snapshot
9.10.4.Operating business segments
9.10.5.Product portfolio
9.10.6.R&D expenditure (Continued and discontinued operations)
9.10.7.Business performance (Continued and discontinued operations)

LIST OF TABLES

TABLE 01.GLOBAL LYCOPENE MARKET, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 02.GLOBAL POWDER LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 03.GLOBAL OTHERS LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 04.GLOBAL LYCOPENE MARKET, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 05.GLOBAL NATURAL LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 06.GLOBAL SYNTHETIC LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 07.GLOBAL LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 08.GLOBAL LYCOPENE MARKET FOR FOOD AND BEVERAGE INDUSTRY, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 09.GLOBAL LYCOPENE MARKET FOR NUTRACEUTICALS AND PHARMACEUTICALS INDUSTRY, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 10.GLOBAL LYCOPENE FOR COSMETICS AND PERSONAL CARE INDUSTRY, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 11.GLOBAL LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)
TABLE 12.NORTH AMERICA LYCOPENE MARKET VALUE, BY FORM 2020–2030 ($ THOUSAND)
TABLE 13.NORTH AMERICA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 14.NORTH AMERICA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 15.NORTH AMERICA LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 16.U.S. LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 17.U.S. LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 18.U.S. LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 19.CANADA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 20.CANADA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 21.CANADA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 22.MEXICO LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 23.MEXICO LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 24.MEXICO LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 25.EUROPE LYCOPENE MARKET VALUE, BY FORM 2020–2030 ($ THOUSAND)
TABLE 26.EUROPE LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 27.EUROPE LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 28.EUROPE LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 29.UK LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 30.UK LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 31.UK LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 32.GERMANY LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 33.GERMANY LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 34.GERMANY LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 35.FRANCE LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 36.FRANCE LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 37.FRANCE LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 38.ITALY LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 39.ITALY LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 40.ITALY LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 41.SPAIN LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 42.SPAIN LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 43.SPAIN LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 44.REST OF EUROPE LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 45.REST OF EUROPE LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 46.REST OF EUROPE LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 47.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY FORM 2020–2030 ($ THOUSAND)
TABLE 48.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 49.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 50.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ THOUSAND)
TABLE 51.CHINA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 52.CHINA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 53.CHINA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 54.JAPAN LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 55.JAPAN LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 56.JAPAN LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 57.INDIA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 58.INDIA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 59.INDIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 60.ASEAN LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 61.ASEAN LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 62.ASEAN LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 63.AUSTRALIA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 64.AUSTRALIA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 65.AUSTRALIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 66.SOUTH KOREA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 67.SOUTH KOREA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 68.SOUTH KOREA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 69.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 70.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 71.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 72.LAMEA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 73.LAMEA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 74.LAMEA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 75.LAMEA LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION)
TABLE 76.BRAZIL LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 77.BRAZIL LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 78.BRAZIL LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 79.ARGENTINA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 80.ARGENTINA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 81.ARGENTINA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 82.SAUDI ARABIA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 83.SAUDI ARABIA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 84.SAUDI ARABIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 85.SOUTH AFRICA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 86.SOUTH AFRICA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 87.SOUTH AFRICA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 88.REST OF LAMEA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)
TABLE 89.REST OF LAMEA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)
TABLE 90.REST OF LAMEA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)
TABLE 91.ALLIED BIOTECH CORPORATION: COMPANY SNAPSHOT
TABLE 92.ALLIED BIOTECH CORPORATION: OPERATING SEGMENTS
TABLE 93.ALLIED BIOTECH CORPORATION: PRODUCT PORTFOLIO
TABLE 94.ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVE
TABLE 95.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
TABLE 96.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
TABLE 97.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
TABLE 98.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 99.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
TABLE 100.AROMATAGROUP SRL: KEY EXECUTIVES
TABLE 101.AROMATAGROUP SRL: COMPANY SNAPSHOT
TABLE 102.AROMATAGROUP SRL: OPERATING SEGMENTS
TABLE 103.AROMATAGROUP SRL: PRODUCT PORTFOLIO
TABLE 104.BASF SE: KEY EXECUTIVES
TABLE 105.BASF SE: COMPANY SNAPSHOT
TABLE 106.BASF SE: OPERATING SEGMENTS
TABLE 107.BASF SE: PRODUCT PORTFOLIO
TABLE 108.BASF SE: NET SALES, 2018-2020 ($MILLION)
TABLE 109.DIVIS LABORATORIES LTD.: KEY EXECUTIVES
TABLE 110.DIVIS LABORATORIES LTD.: COMPANY SNAPSHOT
TABLE 111.DIVIS LABORATORIES LTD.: OPERATING SEGMENTS
TABLE 112.DIVIS LABORATORIES LTD.: PRODUCT PORTFOLIO
TABLE 113.DIVIS LABORATORIES LTD.: NET SALES, 2017–2019 ($MILLION)
TABLE 114.DOEHLER GROUP SE: KEY EXECUTIVES
TABLE 115.DOEHLER GROUP SE: COMPANY SNAPSHOT
TABLE 116.DOEHLER GROUP SE: OPERATING SEGMENTS
TABLE 117.DOEHLER GROUP SE: PRODUCT PORTFOLIO
TABLE 118.EXCELVITE: KEY EXECUTIVES
TABLE 119.EXCELVITE: COMPANY SNAPSHOT
TABLE 120.EXCELVITE: OPERATING SEGMENTS
TABLE 121.EXCELVITE: PRODUCT PORTFOLIO
TABLE 122.GIVAUDANINTERNATIONAL SA: KEY EXECUTIVE
TABLE 123.GIVAUDANINTERNATIONAL SA: COMPANY SNAPSHOT
TABLE 124.GIVAUDANINTERNATIONAL SA: OPERATING SEGMENTS
TABLE 125.GIVAUDANINTERNATIONAL SA: PRODUCT PORTFOLIO
TABLE 126.GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 127.GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
TABLE 128.KALSEC INC: KEY EXECUTIVES
TABLE 129.KALSEC INC: COMPANY SNAPSHOT
TABLE 130.KALSEC INC: OPERATING SEGMENTS
TABLE 131.KALSEC INC: PRODUCT PORTFOLIO
TABLE 132.KONINKLIJKE DSM N.V.: KEY EXECUTIVE
TABLE 133.KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT
TABLE 134.KONINKLIJKE DSM N.V.: OPERATING SEGMENTS
TABLE 135.KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO
TABLE 136.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 137.KONINKLIJKE DSM N.V.: NET SALES, 2018-2020 ($MILLION)

LIST OF FIGURES

FIGURE 01.LYCOPENE MARKET OVERVIEW
FIGURE 02.KEY MARKET SEGMENTS
FIGURE 03.EXECUTIVE SUMMARY
FIGURE 04.TOP IMPACTING FACTORS
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTION
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 11.GLOBAL LYCOPENE MARKET, BY FORM, 2020 (%)
FIGURE 12.COMPARATIVE VALUE SHARE ANALYSIS OF POWDER LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 13.COMPARATIVE VALUE SHARE ANALYSIS OF OTHERS LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.GLOBAL LYCOPENE MARKET, BY NATURE, 2020 (%)
FIGURE 15.COMPARATIVE VALUE SHARE ANALYSIS OF GLOBAL NATURAL LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 16.COMPARATIVE VALUE SHARE ANALYSIS OFSYNTHETIC LYCOPENE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 17.GLOBAL LYCOPENE MARKET, BY APPLICATION, 2020 (%)
FIGURE 18.COMPARATIVE VALUE SHARE ANALYSIS OF LYCOPENE FOR FOOD AND BEVERAGEINDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 19.COMPARATIVE VALUE SHARE ANALYSIS OF LYCOPENE SALES FOR NUTRACEUTICALS AND PHARMACEUTICALS INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 20.COMPARATIVE VALUE SHARE ANALYSIS OF SALES OF LYCOPENE FOR COSMETICS AND PERSONAL CARE INDUSTRY, BY COUNTRY, 2020 & 2030 (%)
FIGURE 21.GLOBAL LYCOPENE MARKET, BY REGION 2020 (%)
FIGURE 22.U.S. LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 23.CANADA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 24.MEXICO LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 25.UK LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 26.GERMANY LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 27.FRANCE LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 28.ITALY LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 29.SPAIN LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 30.REST OF EUROPE LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 31.CHINA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 32.JAPAN LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 33.INDIA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 34.ASEAN LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 35.AUSTRALIA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 36.SOUTH KOREA LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 37.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, 2020-2030 ($ THOUSAND)
FIGURE 38.BRAZIL LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 39.ARGENTINA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 40.SAUDI ARABIA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 41.SOUTH AFRICA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 42.REST OF LAMEA LYCOPENE MARKET VALUE, 2020-2030 ($ MILLION)
FIGURE 43.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 45.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 46.TOP WINNING STRATEGIES, BY YEAR, 2018–2021*
FIGURE 47.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021* (%)
FIGURE 48.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021*
FIGURE 49.PLAYER POSITIONING OF TOP 10 KEY PLAYERS
FIGURE 50.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 51.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
FIGURE 52.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 53.ARCHER DANIELS MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 54.BASF SE: NET SALES, 2018-2020 ($MILLION)
FIGURE 55.BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56.BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57.DIVIS LABORATORIES LTD.: NET SALES, 2017–2019 ($MILLION)
FIGURE 58.DIVIS LABORATORIES LTD.: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59.GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 60.GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)
FIGURE 61.GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 62.GIVAUDANINTERNATIONAL SA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 63.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 64.KONINKLIJKE DSM N.V.: NET SALES, 2018-2020 ($MILLION)
FIGURE 65.KONINKLIJKE DSM N.V.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 66.KONINKLIJKE DSM N.V.: REVENUE SHARE BY REGION, 2020 (%)

Recent years have seen an increase in demand for food ingredients that are healthy and natural. Primary reason for this demand increase is the rising awareness of the several health benefits that are inherent with the consumption of food and beverages that have naturally sourced or nature identical ingredients. It has led to an increase in the use of lycopene as an ingredient in many types of food and beverages.

Lycopene is a natural carotenoid most commonly extracted from tomatoes. Synthetic lycopene is also commonly used to impart a light to dark red color to the food that is being produced. However, the shift in consumer perception that favors natural ingredients has led to a wider adoption of natural lycopene by the engaged stakeholders. The various health benefits associated with lycopene have also led to usage of the same in nutraceutical and cosmetics industries, as there is also a demand for natural supplements and personal care products by the consumers.

There is increased awareness in consumers about negative impact on health due to synthetic ingredients as a result this has led to the introduction of organic lycopene in the market, which is sourced form organically grown tomatoes. Innovations and advancement of extraction technology are expected to provide lucrative opportunities for the engaged stakeholders in the lycopene market.